These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23740963)

  • 1. Corneal response to canakinumab in cryopyrin associated periodic fever syndrome.
    Tsatsos M; Hawkin PN; Hossain P
    Br J Ophthalmol; 2013 Aug; 97(8):1081-2. PubMed ID: 23740963
    [No Abstract]   [Full Text] [Related]  

  • 2. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muckle-Wells syndrome effectively treated with canakinumab: is the recommended dosing schedule mandatory?
    Mueller SM; Itin P; Haeusermann P
    Dermatology; 2011; 223(2):113-8. PubMed ID: 21967869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.
    Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

  • 7. [Canakinumab, a monoclonal antibody against IL-1β, with potential utility in different inflammatory processes].
    Carné X
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():34-7. PubMed ID: 21596185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
    Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
    Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
    [No Abstract]   [Full Text] [Related]  

  • 10. An Adult Patient With a Novel Mutation in NLRP3 Gene Associated With Cryopyrin-Associated Periodic Syndrome Mimicking Adult-Onset Still Disease.
    Ocampo V; Ortiz-Sierra MC; Echeverri AF; Posso-Osorio I; Suso JP; Tobón GJ
    J Clin Rheumatol; 2018 Apr; 24(3):158-159. PubMed ID: 29239927
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment for cryopyrin-associated periodic syndrome.
    Arch Dis Child; 2009 Nov; 94(11):840. PubMed ID: 19846997
    [No Abstract]   [Full Text] [Related]  

  • 12. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
    Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S
    Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
    Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM
    Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRP3.
    Verma D; Eriksson P; Sahdo B; Persson A; Ejdebäck M; Särndahl E; Söderkvist P
    Arthritis Rheum; 2010 Jul; 62(7):2138-43. PubMed ID: 20506209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
    Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
    Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation.
    Alejandre N; Ruiz-Palacios A; García-Aparicio AM; Blanco-Kelly F; Bermúdez S; Fernández-Sanz G; Romero FI; Aróstegui JI; Ayuso C; Jiménez-Alfaro I; Herrero-Beaumont G; Sánchez-Pernaute O
    Rheumatology (Oxford); 2014 Jun; 53(6):1095-9. PubMed ID: 24501247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.
    Kanariou M; Tantou S; Varela I; Raptaki M; Petropoulou C; Nikas I; Valari M
    Pediatrics; 2014 Nov; 134(5):e1468-73. PubMed ID: 25349319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist].
    Rameev VV; Kozlovskaia LV; Bogdanova MV
    Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan.
    Yokota S; Nishikomori R; Takada H; Kikuchi M; Nozawa T; Kanetaka T; Kizawa T; Miyamae T; Mori M; Heike T; Hara T; Imagawa T
    Mod Rheumatol; 2013 May; 23(3):425-9. PubMed ID: 23085882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopyrin-associated periodic syndromes: background and therapeutics.
    Kubota T; Koike R
    Mod Rheumatol; 2010 Jun; 20(3):213-21. PubMed ID: 20140476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.